Anthony. H. Barnett

Anthony. H. Barnett's AcademicInfluence.com Rankings

Anthony. H. Barnett

Philosophy

#4985

World Rank

#7680

Historical Rank

Logic

#2336

World Rank

#3310

Historical Rank

philosophy Degrees

Anthony. H. Barnett

Biology

#6628

World Rank

#9388

Historical Rank

Endocrinology

#64

World Rank

#74

Historical Rank

Biochemistry

#865

World Rank

#972

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Anthony. H. Barnett Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Anthony. H. Barnett's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Congenital leptin deficiency is associated with severe early-onset obesity in humans (1997) (2978)
A genome-wide search for human type 1 diabetes susceptibility genes (1994) (1342)
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility (2014) (933)
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. (2004) (907)
The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. (1996) (815)
Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus (1995) (775)
Diabetes in identical twins (1981) (632)
Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci (2011) (518)
Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study (2012) (510)
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial. (2014) (451)
Antioxidant status in patients with uncomplicated insulin‐dependent and non‐insulin‐dependent diabetes mellitus (1997) (449)
Type 2 diabetes in adolescents and young adults. (2018) (387)
DPP‐4 inhibitors and their potential role in the management of type 2 diabetes (2006) (369)
Increased resistin gene and protein expression in human abdominal adipose tissue. (2002) (366)
A search for type 1 diabetes susceptibility genes in families from the United Kingdom (1998) (341)
Effect of linagliptin monotherapy on glycaemic control and markers of β‐cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial (2011) (314)
Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. (2003) (288)
Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study. (2014) (285)
Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus (2016) (277)
Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males (2005) (263)
SGLT inhibitors in management of diabetes. (2013) (263)
Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial. (2007) (260)
Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping (1989) (247)
Health and population effects of rare gene knockouts in adult humans with related parents (2015) (242)
Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31–q33 (1995) (221)
Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. (2004) (214)
Management of type 2 diabetes: new and future developments in treatment (2011) (205)
A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. (2001) (192)
Glycaemic control in type 2 diabetes: targets and new therapies. (2010) (185)
Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia (2007) (184)
Type 2 diabetes and cardiovascular risk in the UK south Asian community (2006) (180)
The potential impact of periodontal disease on general health: a consensus view (2008) (180)
The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. (1999) (178)
Free radicals and antioxidant systems in health and disease. (1990) (176)
Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin (2012) (173)
The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes (2004) (173)
The effects of androgens and estrogens on preadipocyte proliferation in human adipose tissue: influence of gender and site. (2001) (171)
Genome-Wide Association Study Identifies a Novel Locus Contributing to Type 2 Diabetes Susceptibility in Sikhs of Punjabi Origin From India (2013) (168)
IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus. (1996) (164)
Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial (2013) (163)
Obstructive sleep apnea and diabetic neuropathy: a novel association in patients with type 2 diabetes. (2012) (158)
Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes (2012) (156)
11β-Hydroxysteroid dehydrogenase Type 1 activity in lean and obese males with Type 2 diabetes mellitus (2004) (153)
Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine. (1996) (151)
Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study (2009) (150)
Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study. (1998) (148)
Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status. (2002) (144)
Insulin gene region–encoded susceptibility to type 1 diabetes is not restricted to HLA–DR4–positive individuals (1992) (139)
Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro. (2002) (139)
Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature (2012) (132)
Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management (2007) (130)
Ceiling culture of mature human adipocytes: use in studies of adipocyte functions. (2000) (128)
The human red blood cell glyoxalase system in diabetes mellitus. (1989) (127)
Association of simple anthropometric measures of obesity with visceral fat and the metabolic syndrome in male Caucasian and Indo‐Asian subjects (2004) (126)
Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial) (2012) (124)
The efficacy of self‐monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release–based regimen. A multicentre, randomized, parallel‐group, 6‐month evaluation (DINAMIC 1 study) (2008) (120)
17Beta-estradiol and anti-estrogen ICI:compound 182,780 regulate expression of lipoprotein lipase and hormone-sensitive lipase in isolated subcutaneous abdominal adipocytes. (2003) (117)
Association between stress and glycemic control in adults with type 1 (insulin-dependent) diabetes. (1999) (115)
The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010 (2013) (115)
Vitamin C metabolites and microangiopathy in diabetes mellitus. (1987) (110)
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis (2010) (108)
Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort) (2003) (106)
Molecular aspects of type 1 diabetes (2003) (105)
Evaluation of delivery of enhanced diabetes care to patients of South Asian ethnicity: the United Kingdom Asian Diabetes Study (UKADS) (2004) (104)
Poor Glycaemic Control is Associated with Reduced Serum Free Radical Scavenging (Antioxidant) Activity in Non-Insulin-Dependent Diabetes Mellitus (1997) (104)
Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations (2011) (99)
Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus (2009) (99)
Glucocorticoid regulation of p450 aromatase activity in human adipose tissue: gender and site differences. (2002) (97)
Evaluation of fine mapping strategies for a multifactorial disease locus: systematic linkage and association analysis of IDDM1 in the HLA region on chromosome 6p21. (2000) (97)
Tumour necrosis factor-α exerts dual effects on human adipose leptin synthesis and release (2000) (96)
Safety and tolerability of linagliptin: a pooled analysis of data from randomized controlled trials in 3572 patients with type 2 diabetes mellitus (2012) (94)
What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes. (2012) (93)
Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. (1997) (92)
Dapagliflozin compared with other oral anti‐diabetes treatments when added to metformin monotherapy: a systematic review and network meta‐analysis (2014) (92)
Higher Prevalence of Retinopathy in Diabetic Patients of South Asian Ethnicity Compared With White Europeans in the Community (2009) (92)
Can insulin-treated diabetics be given beta-adrenergic blocking drugs? (1980) (90)
Premature cardiovascular events and mortality in south Asians with type 2 diabetes in the United Kingdom Asian Diabetes Study – effect of ethnicity on risk (2010) (87)
The molecular basis of the Kidd blood group polymorphism and its lack of association with type 1 diabetes susceptibility. (1997) (86)
Serum antioxidant activity in diabetes mellitus. (1988) (86)
Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes (2010) (83)
Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study (2011) (82)
CHLORPROPAMIDE ALCOHOL FLUSHING AND DIABETIC RETINOPATHY (1979) (81)
Future glucose-lowering drugs for type 2 diabetes. (2016) (80)
Familial early-onset type 2 diabetes in Chinese patients: obesity and genetics have more significant roles than autoimmunity. (2001) (80)
Pigmentary retinal dystrophy and the syndrome of maternally inherited diabetes and deafness caused by the mitochondrial DNA 3243 tRNA(Leu) A to G mutation. (1999) (79)
FREE RADICAL AND AUTO-OXIDANT SYSTEMS IN HEALTH AND DISEASE (1990) (77)
Effects of 16 Genetic Variants on Fasting Glucose and Type 2 Diabetes in South Asians: ADCY5 and GLIS3 Variants May Predispose to Type 2 Diabetes (2011) (77)
Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in south-Asians (2006) (77)
Lixisenatide: evidence for its potential use in the treatment of type 2 diabetes (2011) (76)
The genetics of diabetic complications. (1986) (75)
Factors associated with clinic non‐attendance in adults with Type 1 diabetes mellitus (1998) (73)
Association of Apolipoprotein ε2 Allele With Diabetic Nephropathy in Caucasian Subjects With IDDM (1998) (72)
HLA-DQA1 and -DQB1 Alleles Associated With Genetic Susceptibility to IDDM in a Black Population (1991) (71)
Emerging treatment options for type 2 diabetes. (2010) (71)
Genetic determinants of diabetic nephropathy. (1999) (70)
The HLA-DPB1--associated component of the IDDM1 and its relationship to the major loci HLA-DQB1, -DQA1, and -DRB1. (2001) (69)
Dexamethasone inhibits tumor necrosis factor-α-induced apoptosis and interleukin-1β release in human subcutaneous adipocytes and preadipocytes1 (2001) (68)
Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation (1991) (68)
Higher prevalence of retinopathy in diabetic patients of south Asian ethnicity compared to white Europeans in the community : a cross sectional study (2008) (67)
Metabolic studies in unaffected co-twins of non-insulin-dependent diabetics. (1981) (65)
Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study* (2005) (65)
Adherence patterns in patients with type 2 diabetes on basal insulin analogues: missed, mistimed and reduced doses (2012) (65)
Saturation multipoint linkage mapping of chromosome 6q in type 1 diabetes. (1996) (64)
Securing recruitment and obtaining informed consent in minority ethnic groups in the UK (2008) (64)
Nitric oxide synthase gene polymorphisms and diabetic nephropathy (2003) (64)
Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18‐week randomized, double‐blind, placebo‐controlled phase III trial with a 34‐week active‐controlled extension (2012) (63)
Exubera inhaled insulin: a review (2004) (63)
Telomere Length Attrition, a Marker of Biological Senescence, Is Inversely Correlated with Triglycerides and Cholesterol in South Asian Males with Type 2 Diabetes Mellitus (2012) (62)
11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus. (2004) (62)
Obstructive Sleep Apnea and Retinopathy in Patients with Type 2 Diabetes. A Longitudinal Study (2017) (62)
A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies (2007) (61)
Evidence for a type 1 diabetes susceptibility locus (IDDM10) on human chromosome 10p11-q11. (1997) (61)
The HLA association with Graves' disease is sex‐specific in Hong Kong Chinese subjects (1994) (61)
Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real-life worldwide observational study (EDGE) (2013) (61)
SPECIFIC THROMBOXANE SYNTHETASE INHIBITION AND ALBUMIN EXCRETION RATE IN INSULIN-DEPENDENT DIABETES (1984) (60)
Lack of association between polymorphism of the thyrotropin receptor gene and Graves' disease in United Kingdom and Hong Kong Chinese patients: case control and family-based studies. (1998) (60)
Novel therapeutics for type 2 diabetes: insulin resistance (2015) (58)
Saxagliptin Add-on Therapy to Insulin With or Without Metformin for Type 2 Diabetes Mellitus: 52-Week Safety and Efficacy (2013) (57)
Redefining the role of thiazolidinediones in the management of type 2 diabetes (2009) (57)
An investigation of the relationship between free radical activity and vitamin C metabolism in elderly diabetic subjects with retinopathy. (1992) (57)
The British Diabetic Association--Warren repository. (1990) (57)
Type 2 diabetes and cardiovascular risk in the UK south Asian community (2006) (56)
High-resolution linkage mapping for susceptibility genes in human polygenic disease: insulin-dependent diabetes mellitus and chromosome 11q. (1991) (56)
Low serum C4 concentrations: an inherited predisposition to insulin dependent diabetes? (1983) (56)
Inhibitory effect of superoxide dismutase on fructosamine assay. (1987) (56)
Prevention of loss of renal function over time in patients with diabetic nephropathy. (2006) (56)
Obstructive Sleep Apnea and Diabetic Nephropathy (2013) (55)
New treatments in type 2 diabetes: a focus on the incretin‐based therapies (2009) (55)
Rosiglitazone inhibits the insulin‐mediated increase in PAI‐1 secretion in human abdominal subcutaneous adipocytes (2003) (55)
The role of GLP-1 mimetics and basal insulin analogues in type 2 diabetes mellitus: guidance from studies of liraglutide (2012) (54)
A systematic review of lifestyle modification and glucose intolerance in the prevention of type 2 diabetes. (2010) (54)
Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome (2011) (54)
Susceptibility to IDDM in a Chinese Population: Role of HLA Class II Alleles (1992) (53)
Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians (2012) (53)
Common variants of the TCF7L2 gene are associated with increased risk of type 2 diabetes mellitus in a UK-resident South Asian population (2008) (52)
Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs (2012) (52)
Analysis of the CD3 gene region and type 1 diabetes: application of fluorescence-based technology to linkage disequilibrium mapping. (1995) (51)
Clinical and Neurophysiological Studies of Aldose Reductase Inhibitor Ponalrestat in Chronic Symptomatic Diabetic Peripheral Neuropathy (1991) (51)
A heterozygous deletion of the autoimmune regulator (AIRE1) gene, autoimmune thyroid disease, and type 1 diabetes: no evidence for association. (2000) (50)
The A-G polymorphism in exon 1 of theCTLA-4 gene is not associated with systemic lupus erythematosus (1999) (50)
Circadian Gene Variants and Susceptibility to Type 2 Diabetes: A Pilot Study (2012) (50)
Preventing renal complications in type 2 diabetes: results of the diabetics exposed to telmisartan and enalapril trial. (2006) (49)
Glucokinase Activators for Type 2 Diabetes: Challenges and Future Developments (2020) (49)
Treating to goal: challenges of current management. (2004) (48)
MICROALBUMINURIA AND DIABETIC RETINOPATHY (1985) (48)
Transfer factor for carbon monoxide in patients with diabetes with and without microangiopathy. (1988) (47)
Chlorpropamide-alcohol flushing and large-vessel disease in non-insulin-dependent diabetes. (1980) (47)
Tumour necrosis factor-alpha exerts dual effects on human adipose leptin synthesis and release. (2000) (46)
Insulin increases angiotensinogen expression in human abdominal subcutaneous adipocytes (2003) (46)
Quantitative assessment of serum and urinary polyclonal free light chains in patients with type II diabetes: an early marker of diabetic kidney disease? (2008) (45)
Prevalence of microalbuminuria and hypertension in South Asians and white Europeans with type 2 diabetes: a report from the United Kingdom Asian Diabetes Study (UKADS) (2006) (45)
Blood concentrations of acetaldehyde during chlorpropamide-alcohol flush. (1981) (45)
Treatment With the Dipeptidyl Peptidase-4 Inhibitor Linagliptin or Placebo Followed by Glimepiride in Patients With Type 2 Diabetes With Moderate to Severe Renal Impairment: A 52-Week, Randomized, Double-Blind Clinical Trial (2015) (45)
Platelet Aggregation and Coagulation Factors in Insulin Dependent Diabetics With and Without Microangiopathy (1987) (45)
Why is Exubera being withdrawn? (2007) (45)
Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM (1996) (45)
Modulators of free radical activity in diabetes mellitus: role of ascorbic acid. (1992) (44)
BLOCKADE OF CHLORPROPAMIDE-ALCOHOL FLUSHING BY INDOMETHACIN SUGGESTS AN ASSOCIATION BETWEEN PROSTAGLANDINS AND DIABETIC VASCULAR COMPLICATIONS (1980) (44)
Dexamethasone inhibits tumor necrosis factor-alpha-induced apoptosis and interleukin-1 beta release in human subcutaneous adipocytes and preadipocytes. (2001) (43)
Pathogenesis of diabetic microangiopathy: an overview. (1991) (42)
High concentrations of thyroid-stimulating hormone in untreated glucocorticoid deficiency: indication of primary hypothyroidism? (1982) (42)
DPP-4 Inhibitors in Clinical Practice (2009) (41)
Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly Type 2 diabetic patients (1998) (41)
The influence of HLA-DR and -DQ alleles on progression to multiple sclerosis following a clinically isolated syndrome. (1993) (40)
Insulin Glargine in the Treatment of Type 1 and Type 2 Diabetes (2006) (40)
Nephropathy in Type 1 Diabetes: the Role of Genetic Factors (1995) (39)
Special needs of elderly diabetic patients. (1993) (39)
Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy. (1993) (38)
Angiotensin‐Converting Enzyme (ACE): Relationship to Insulin‐dependent Diabetes and Microangiopathy (1986) (38)
Prolonged Aldose Reductase Inhibition in Chronic Peripheral Diabetic Neuropathy: Effects on Microangiopathy (1990) (38)
Intrinsic site-specific differences in the expression of leptin in human adipocytes and its autocrine effects on glucose uptake. (1999) (38)
Development of alternative methods of data collection in South Asians with Type 2 diabetes (2008) (37)
Mutation of the glucagon receptor gene and diabetes mellitus in the UK: association or founder effect? (1995) (37)
Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin‐dependent diabetes mellitus (1997) (37)
Impact of Sodium Glucose Cotransporter 2 Inhibitors on Weight in Patients With Type 2 Diabetes Mellitus (2013) (37)
Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type 1 or type 2 diabetes mellitus. (2011) (36)
Mitochondrial gene defects in patients with NIDDM (1994) (36)
Effect of the orlistat on serum endotoxin lipopolysaccharide and adipocytokines in South Asian individuals with impaired glucose tolerance (2008) (35)
The promoter polymorphism -232C/G of the PCK1 gene is associated with type 2 diabetes in a UK-resident South Asian population (2009) (35)
The TGF‐β1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes (2005) (34)
Safety and efficacy of the dipeptidyl peptidase‐4 inhibitor linagliptin in elderly patients with type 2 diabetes: a comprehensive analysis of data from 1331 individuals aged ≥ 65 years (2014) (34)
An investigation of HLA-encoded genetic susceptibility to multiple sclerosis in subjects of Asian Indian and Afro-Caribbean ethnic origin. (1995) (34)
Parental Origin of Diabetes-Associated HLA Types in Sibling Pairs With Type I Diabetes (1994) (34)
Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes (2010) (34)
Linagliptin: a novel dipeptidyl peptidase 4 inhibitor with a unique place in therapy (2011) (33)
Obstructive sleep apnoea in patients with type 2 diabetes: aetiology and implications for clinical care (2009) (33)
Long‐term tolerability of inhaled human insulin (Exubera®) in patients with poorly controlled type 2 diabetes (2007) (32)
Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implications for insulin resistance and cardiovascular risks (2008) (32)
Site-specific regulation of oestrogen receptor-alpha and -beta by oestradiol in human adipose tissue. (2001) (32)
A review of basal insulins (2003) (31)
The British Diabetic Association -Warren Repository (1990) (31)
Avoiding hypoglycaemia while achieving good glycaemic control in type 2 diabetes through optimal use of oral agent therapy (2010) (31)
Low plasma C4 concentrations: association with microangiopathy in insulin dependent diabetes. (1984) (31)
Rationale and design of diabetics exposed to telmisartan and enalapril (DETAIL) study. (2000) (31)
The 5 ′-end polymorphism of the aldose reductase gene is not associated with diabetic nephropathy in Caucasian Type I diabetic patients (1999) (31)
Relation of gene expression (allotypes) of the fourth component of complement to insulin dependent diabetes and its microangiopathic complications. (1985) (30)
Prevalence and Associations of Obstructive Sleep Apnea in South Asians and White Europeans with Type 2 Diabetes: A Cross-Sectional Study. (2017) (30)
Comparison of the free radical scavenging activity of captopril versus enalapril: a three month in vivo study in hypertensive diabetic patients. (1991) (30)
SGLT-2 inhibitors in development for type 2 diabetes treatment. (2011) (30)
Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent IgG and lipid peroxides in non-insulin dependent diabetes mellitus. (1988) (30)
Future challenges and therapeutic opportunities in type 2 diabetes: Changing the paradigm of current therapy (2017) (30)
Cross‐cultural comparisons of anxiety and depression in adults with type 1 diabetes (2003) (29)
Effects of taspoglutide on glycemic control and body weight in obese patients with type 2 diabetes (T‐emerge 7 study) (2013) (29)
Patients presenting with Addison's disease need not be pigmented. (1982) (29)
Genetic susceptibility to multiple sclerosis in a Shanghai Chinese population. The role of the HLA class II genes. (1995) (28)
Starting insulin therapy with basal insulin analog or premix insulin analog in T2DM: a pooled analysis of treat-to-target trials (2010) (28)
Cost-effective strategies in the prevention of diabetic nephropathy (2004) (28)
Renal protection with angiotensin receptor blockers: where do we stand. (2011) (28)
Treatment intensification in patients with type 2 diabetes (2008) (28)
Detection of impaired glucose tolerance and undiagnosed type 2 diabetes in UK South Asians: an effective screening strategy (2008) (28)
Genetic and immunological characteristics of Type I diabetes mellitus in an Indo-Aryan population (2000) (28)
Incidence, worry and discussion about dosing irregularities and self‐treated hypoglycaemia amongst HCPs and patients with type 2 diabetes: results from the UK cohort of the Global Attitudes of Patient and Physicians (GAPP2) survey (2014) (27)
Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study. (1993) (27)
Effect of bromocriptine on maturity onset diabetes. (1980) (27)
The role of cilostazol in the treatment of intermittent claudication (2004) (26)
UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study) (2009) (26)
Drug evaluation: Vildagliptin-metformin single-tablet combination (2009) (26)
Dosing of insulin glargine in the treatment of type 2 diabetes. (2007) (26)
Expression of calcitonin gene-related peptide, adrenomedullin, and receptor modifying proteins in human adipose tissue and alteration in their expression with menopause status (2007) (26)
Peripheral and Autonomic Neuropathy in South Asians and White Caucasians with Type 2 Diabetes Mellitus: Possible Explanations for Epidemiological Differences (2017) (26)
Urinary Transferrin Excretion in Type 1 (Insulin‐dependent) Diabetes Mellitus (1991) (26)
DIABETES AND HYPERTENSION (1978) (25)
Diabetic impotence: risk factors in a clinic population. (1987) (25)
Inhaled insulin: new technology, new possibilities (2006) (25)
An alternative explanation for the changes in erythrocyte fatty acids observed in diabetes mellitus. (1987) (25)
Treatment adherence with vildagliptin compared to sulphonylurea as add-on to metformin in Muslim patients with type 2 diabetes mellitus fasting during Ramadan (2013) (25)
Chlorpropamide-alcohol flushing and proteinuria in non-insulin-dependent diabetics. (1981) (24)
Complementing Insulin Therapy to Achieve Glycemic Control (2013) (24)
An investigation of Japanese subjects maps susceptibility to type 1 (insulin-dependent) diabetes mellitus close to the DQA1 gene. (1992) (23)
Role of Reactive Oxygen Species in the Generation of Fluorescence by Glycation (1992) (23)
Study of possible risk factors for severe retinopathy in non-insulin dependent diabetes. (1983) (23)
Muscle Capillary Basement Membrane in Identical Twins Discordant for Insulin-dependent Diabetes (1983) (23)
The importance of treating cardiometabolic risk factors in patients with type 2 diabetes (2008) (22)
Identification of susceptibility loci for Type 1 (insulin-dependent) diabetes by trans-racial gene mapping (1990) (22)
Phenotypes of the heavy chains of immunoglobulins in patients with diabetic microangiopathy: evidence for an immunogenetic predisposition. (1986) (22)
Conditional ETDT analysis of the Human Leukocyte Antigen region in type 1 diabetes (2000) (22)
Consequences of delaying treatment intensification in type 2 diabetes: evidence from a UK database (2016) (22)
Insulin for type 2 diabetes: choosing a second-line insulin regimen (2008) (21)
High frequency of autoantibodies in patients with long duration type 1 diabetes (2013) (21)
The TGF-beta 1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes. (2005) (21)
An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Meformin as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on a Sulfonylurea (2006) (21)
Transferrinuria in Type 2 Diabetes: The Effect of Glycaemic Control (1991) (21)
Exenatide once weekly: clinical outcomes and patient satisfaction (2010) (21)
7 Trans-racial gene mapping studies (1991) (21)
Risk of Breast Cancer by Individual Insulin Use: An International Multicenter Study (2013) (20)
Diabetes in the UK West Indian Community: the Wolverhampton Survey (1989) (20)
How well do rapid‐acting insulins work in obese individuals? (2006) (20)
HLA-DQ and DRB1 polymorphism and susceptibility to type 1 diabetes in Jamaica. (2002) (20)
Asian patients attending a diabetic clinic. (1985) (20)
A comparison of foetal and labour outcomes in Caucasian and Afro‐Caribbean women with diabetes in pregnancy (2004) (19)
Glomerular filtration rate determination in diabetic patients using iohexol clearance--comparison of single and multiple plasma sampling methods. (1998) (19)
A placebo‐controlled crossover study comparing the effects of nateglinide and glibenclamide on postprandial hyperglycaemia and hyperinsulinaemia in patients with type 2 diabetes (2004) (19)
Inhaled insulin (Exubera®): combining efficacy and convenience (2006) (19)
Pharmacotherapy for obesity in menopausal women (2008) (19)
Comparative risk of microalbuminuria and proteinuria in UK residents of south Asian and white European ethnic background with type 2 diabetes: a report from UKADS (2011) (19)
Multicentre study to assess quality of life and glycaemic control of Type 2 diabetic patients treated with insulin compared with oral hypoglycaemic agents (1996) (19)
HLA alleles and IDDM in children in Hungary: a comparison with Finland. (2001) (18)
Evidence for a Type 1 diabetes‐specific mechanism for the insulin gene‐associated IDDM2 locus rather than a general influence on autoimmunity (2004) (18)
Expert opinion statement on the use of insulin therapy in patients with type 2 diabetes in primary care (2003) (18)
Is candidiasis the true cause of vulvovaginal irritation in women with diabetes mellitus? (1990) (18)
Linagliptin added to sulphonylurea in uncontrolled type 2 diabetes patients with moderate-to-severe renal impairment (2014) (17)
A look into the future: improving diabetes care by 2015 (2011) (17)
Human leucocyte antigen and insulin gene regions and nephropathy in Type I diabetes (1999) (17)
Elevated Serum Free Light Chains Predict Cardiovascular Events in Type 2 Diabetes (2014) (17)
Increasing awareness of hypoglycaemia in patients with Type 2 diabetes treated with oral agents (2013) (17)
Both DQA1 and DQB1 genes are implicated in HLA-associated protection from type 1 (insulin-dependent) diabetes mellitus in a British Caucasian population (1993) (17)
Genetics of type 1 diabetes. (2001) (17)
The genetics of type I (insulin dependent) diabetes mellitus. (1992) (16)
Trans-racial studies implicate HLA-DQ as a component of genetic susceptibility to Type 1 (insulin-dependent) diabetes (1988) (16)
Platelet Behaviour and Haemostatic Variables in Type 1 (Insulin‐dependent) Diabetic Patients With and Without Albuminuria (1991) (16)
Low preoperative selenium is associated with post-operative atrial fibrillation in patients having intermediate-risk coronary artery surgery (2016) (16)
The Incretin System (2013) (16)
The aetiology of Type 1 diabetes (1999) (16)
HRT in women with diabetes--review of the effects on glucose and lipid metabolism. (2001) (16)
Dipeptidyl peptidase-4 inhibitors in triple oral therapy regimens in patients with type 2 diabetes mellitus (2015) (16)
The interleukin-1 receptor antagonist gene shows no allelic association with three autoimmune diseases. (1999) (16)
Activity of the Unstimulated Renin—Angiotensin—Aldosterone System in Type 1 Diabetic Patients with and without Proteinuria (1989) (15)
Empagliflozin for the treatment of type 2 diabetes (2014) (15)
Detection of human apolipoprotein E3, E2, and E4 genotypes by an allele-specific oligonucleotide-primed polymerase chain reaction assay: development and validation. (1991) (15)
The Role of Angiotensin II Receptor Antagonists in the Management of Diabetes (2001) (15)
Physical activity and risk of diabetes (2008) (14)
Hypertriglyceridaemia is associated with an increased likelihood of albuminuria in extreme duration (> 50 years) Type 1 diabetes (2008) (14)
The new NICE guidelines for type 2 diabetes – a critical analysis (2015) (14)
An investigation of the association between HLA-DQ heterodimers and type 1 (insulin-dependent) diabetes mellitus in five racial groups. (1993) (14)
Mini-pump: method of diabetic control during minor surgery under general anaesthesia. (1980) (14)
Insulin receptor antibodies in diabetes mellitus. (1988) (14)
Class II HLA DNA polymorphisms in Type 1 (insulin-dependent) diabetic patients of North Indian origin (1988) (14)
An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin (2006) (14)
Origin of the microangiopathic changes in diabetes (1993) (14)
Components of the Diet Associated with Child Adiposity: A Cross-Sectional Study (2011) (13)
The Incretin System and Type 2 Diabetes (2009) (13)
Genetic variants conferring susceptibility to Alzheimer’s disease in the general population; do they also predispose to dementia in Down’s syndrome (2014) (13)
Abnormal Platelet Aggregation in Chronic Symptomatic Diabetic Peripheral Neuropathy (1986) (13)
PROTEIN BROWNING AND DIABETIC COMPLICATIONS (1986) (13)
Safety of fluconazole in women taking oral hypoglycaemic agents (1992) (13)
HLA-DR and DQ DNA polymorphisms in subjects of Asian Indian and white Caucasian origin. (1988) (12)
Use of a seaweed‐based dressing in management of leg ulcers in diabetics: A case report (1987) (12)
Polymorphisms of Interleukin 4 Receptor Gene and Interleukin 10 Gene are not Associated with Graves' Disease in the UK (2004) (12)
Insulin degludec: a new ultra-longacting insulin (2012) (12)
West Indian diabetic population of a large inner city diabetic clinic. (1981) (12)
A Patient-level Analysis of Efficacy and Hypoglycaemia Outcomes Across Treat-to-target Trials with Insulin Glargine Added to Oral Antidiabetes Agents in People with Type 2 Diabetes. (2014) (12)
Improved Diabetes Control and Knowledge During a Diabetes Self-Help Group (1987) (11)
The aetiology of Type I diabetes. (1999) (11)
35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
Allele-specific gene probing supports the DQ molecule as a determinant of inherited susceptibility to Type 1 (insulin-dependent) diabetes mellitus (1991) (11)
Low molecular weight proteinuria in insulin-dependent diabetes. (1986) (11)
Drug treatment of the hypertensive diabetic. (1988) (10)
Increased Urinary Transferrin Excretion in Exercising Normoalbuminuric Insulin-Dependent Diabetic Patients (1991) (10)
Genetics of diabetes. Trans-racial gene mapping studies. (1991) (10)
Serum fructosamine in diabetic pregnancy. (1989) (10)
Using self-complete questionnaires in a South Asian population with diabetes: problems and solutions (2006) (10)
DRB genotyping supports recessive inheritance of DR3-associated susceptibility to insulin-dependent diabetes mellitus. (1991) (10)
Perceptions of diabetes control among physicians and people with type 2 diabetes uncontrolled on basal insulin in Sweden, Switzerland, and the United Kingdom (2016) (10)
Immunoglobulin heavy chain phenotypes and background retinopathy in non-insulin dependent diabetics. (1988) (9)
Individual patient data meta-analysis of trials of self-monitoring of blood glucose in non-insulin treated type 2 diabetes: protocol for a systematic review. (2009) (9)
CIRCULATING PROSTANOID LEVELS, BOTH BASAL AND DURING THE CHLORPROPAMIDE ALCOHOL FLUSH, IN NON‐INSULIN DEPENDENT DIABETES (1981) (9)
Sodium transport across erythrocyte membranes in diabetes mellitus. (1986) (9)
Translating science into clinical practice: focus on vildagliptin in combination with metformin (2009) (9)
Phenotypic characteristics and risk factors in a multi-ethnic cohort of young adults with type 2 diabetes (2019) (9)
Inhaled human insulin (Exubera®): clinical profile and patient considerations (2007) (9)
Transfer from animal insulins to semisynthetic human insulin: a study in four centres. (1990) (9)
DISSEMINATED INTRAVASCULAR COAGULATION IN DIABETIC KETOACIDOSIS (1979) (9)
Linagliptin for the treatment of type 2 diabetes mellitus: a drug safety evaluation (2015) (9)
Cardiovascular benefits of incretins (2013) (9)
Pre-conception counselling, birth weight, and congenital abnormalities in established and gestational diabetic pregnancy. (1987) (8)
MRI total sagittal abdominal diameter as a predictor of metabolic syndrome compared to visceral fat at L4-L5 level. (2008) (8)
Switching from sitagliptin to liraglutide to manage patients with type 2 diabetes in the UK: A long‐term cost‐effectiveness analysis (2018) (8)
NICE draft type 2 diabetes guidelines: a cause for concern. (2015) (8)
A predominantly adrenaline-secreting phaeochromocytoma. (1990) (8)
Microalbuminuria in diabetic subjects with chronic peripheral neuropathy. (1988) (8)
Sequencing of the Second Exon of the MHC Class II DQ6 Alleles in Patients with Type 1 Diabetes (2002) (8)
The insulin gene region and susceptibility to insulin-dependent diabetes mellitus in four races; new insights from Afro-Caribbean race-specific haplotypes. (1997) (8)
HAZARDS OF COMBINED BETA-BLOCKER/DIURETIC TABLETS (1985) (8)
Thiazolidinediones and cardiovascular outcomes (2008) (8)
Tablet and Insulin Therapy in Type 2 Diabetes in the Elderly (1994) (8)
The HLA-D associations of Type 1 (insulin-dependent) diabetes in Punjabi Asians in the United Kingdom (1987) (8)
Inhaled insulin: new formulation, new trial (2010) (8)
Chlorpropamide-alcohol flush reaction and isoenzyme profiles of alcohol dehydrogenase and aldehyde dehydrogenase. (1986) (8)
What factors influence concordance with medications? Findings from the UK Asian Diabetes study (2014) (7)
The nucleotide sequence of a new DMB allele, DMB*0106. (2000) (7)
A clinical evaluation of the B‐D Pen (1992) (7)
Management of lipids in patients with diabetes (2003) (7)
Management of premature labour in diabetic pregnancy (1980) (7)
Hearing the voices of service users; reflections on researching the views of people from South Asian backgrounds (2008) (7)
Pathogenesis of diabetic nephropathy (1996) (7)
Efficacy and Safety of Linagliptin in Elderly Patients (≥70 Years) With Type 2 Diabetes (2012) (6)
Immunogenetics of insulin-dependent diabetes (1987) (6)
Cardiovascular risk factors and their management in 1282 adult people with type 1 diabetes (2007) (6)
Analysis of MHC class II DNA polymorphisms in Negroid subjects. (1990) (6)
Analysis of a Chinese population suggests that the TNFB gene is not a susceptibility gene for Graves' disease. (1994) (6)
Bariatric surgery – not to be taken lightly (2009) (6)
Diene conjugates and microangiopathy. (1989) (6)
Investigation of the mode of inheritance of insulin-dependent diabetes mellitus in Japanese subjects. (1992) (6)
Some recent advances in non-communicable diseases in the tropics. 2. Diabetes mellitus in the tropics. (1991) (6)
A burning mouth associated with the use of hormone replacement therapy (2005) (6)
Microvascular and cardiovascular disease in South Asians: the emerging challenge (2007) (6)
Immunoglobulin Heavy Chain Phenotypes in Diabetic Microangiopathy Evidence for an Immunogenetic Predisposition (1986) (6)
Sharing of susceptibility loci between autoimmune diseases: lack of association of the insulin gene region with Graves' disease. (1999) (6)
Autoantibodies in Indian-Asians with insulin-dependent diabetes in the UK. (1988) (6)
Obstructive sleep apnoea predicts the development of preproliferative and proliferative retinopathy in patients with type 2 diabetes:a longitudinal analysis (2013) (6)
COXSACKIE B VIRUS AND JUVENILE-ONSET INSULIN-DEPENDENT DIABETES (1985) (5)
Exenatide: incretin therapy for patients with Type 2 diabetes mellitus (2008) (5)
Hormone replacement therapy in women with diabetes mellitus: A survey of knowledge of risks and benefits (1998) (5)
Erratum to: Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis (2010) (5)
A novel PCR-based methodology to determine TAP allele frequencies in population studies. (1998) (5)
Lack of association between type 1 diabetes and the glucokinase gene (1992) (5)
CHLORPROPAMIDE ALCOHOL FLUSHING (1981) (5)
Chlorpropamide-alcohol flushing and microangiopathy in insulin-dependent diabetes. (1981) (5)
Reply to “Insulin expression: is VNTR allele 698 really anomalous?” (1995) (5)
Memories of the early years of insulin treatment in the UK (2003) (5)
Collagen-linked fluorescence in diabetes mellitus. (1986) (5)
Bariatric surgery: a cure for diabetes? (2009) (5)
Inhaled insulin : overcoming barriers to insulin therapy? : review (2006) (5)
Potential role of oral DPP‐4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents (2007) (5)
Sulbactam/ampicillin: effects on glucose metabolism in diabetics with soft tissue infection. (1985) (5)
Captopril inhibits the fluorescence development associated with glycation of proteins. (1992) (5)
Review: Inhaled insulin: overcoming barriers to insulin therapy? (2006) (5)
Summarising the use of thiazolidinediones with insulin (2007) (4)
Chronic kidney disease in long duration type 1 diabetes lasting more than 50 years (2009) (4)
Erratum to: Saxagliptin: a New DPP-4 inhibitor for the treatment of type 2 diabetes mellitus (2009) (4)
Inhibition of the renin-angiotensin system in diabetic patients: beyond HOPE (2004) (4)
Diabetic Control and the Effect of Changing a Diabetic Clinic to Modern Management (1985) (4)
The Incretin Mimetics (2013) (4)
The future of inhaled insulin and incretinmimetics in the management of diabetes. (2008) (4)
Frequency of Latent Autoimmune Diabetes in Adults in Asian Patients Diagnosed as Type 2 Diabetes in Birmingham, United Kingdom (2003) (4)
MRI total sagittal abdominal diameter as a predictor of metabolic syndrome compared to visceral fat at L4–L5 level (2008) (4)
Evidence-based prescribing of diabetes medications: are we getting closer? (2020) (4)
Rapid healing of ulcerated necrobiosis lipoidica with optimum glycaemic control and seaweed‐based dressings (1991) (4)
Coffee consumption as trigger for diabetes in childhood (1990) (4)
Dipeptidyl Peptidase‐4 Inhibitors (2013) (4)
HLA-DQB1 upstream regulatory region polymorphism and type I diabetes. (1996) (4)
The Heart Outcomes Protection Evaluation (HOPE) study: relevance to ophthalmological practice? (2000) (4)
Haemodynamic and hormonal responses to exercise: Studies in patients with diabetes mellitus and adrenomedullary deficiency (1986) (4)
New Mechanisms in Glucose Control: Barnett/New Mechanisms in Glucose Control (2011) (4)
safety and efficacy of linagliptin in elderly Patients With type 2 Diabetes: evidence From 1331 Individuals Aged ≥ 65 Years (2012) (4)
Abnormal blood pressure response to exercise in normoalbuminuric insulin dependent diabetic patients. (1991) (4)
Opiate receptors and the metabolic response to intravenous glucose. (1982) (3)
Genetics of diabetes mellitus. (1994) (3)
RACE-SPECIFIC DR-DQ HAPLOTYPES ALLOW FINER MAPPING OF GENETIC SUSCEPTIBILITY TO TYPE-1 (INSULIN-DEPENDENT) DIABETES (1989) (3)
Treatment options for type 2 diabetes: introducing the incretin-based therapies (2009) (3)
Impact of microangiopathy on chronic symptomatic peripheral neuropathy. (1990) (3)
Dyslipidaemia in ethnic populations : special considerations (2005) (3)
Diabetes, Obesity and Cardiovascular Disease — Therapeutic Implications (2006) (3)
Management of type 2 diabetes: the GLP‐1 pathway (2008) (3)
Low C4 levels in Type 1 (insulin-dependent) diabetes (1987) (3)
Dissociation of changes in sodium transport in erythrocytes from changes in blood pressure. (1985) (3)
New treatments for type 2 diabetes in the UK - an evolving landscape. (2011) (3)
The continuing debate on self-monitoring of blood glucose in diabetes (2005) (2)
Analysis of the role of DPB1-encoded amino acids in the genetic predisposition to type I diabetes mellitus. (2002) (2)
Microalbuminuria and insulin resistance in diabetes mellitus (1993) (2)
Novel metabolic drugs for the management of type 2 diabetes (2006) (2)
The revised NICE draft guideline for type 2 diabetes: still a long way to go. (2015) (2)
Chronic kidney disease in long duration type 1 diabetes lasting more than 50 years. (2009) (2)
PARTIAL PRESERVATION OF PANCREATIC BETACELL FUNCTION IN CHILDREN WITH DIABETES (1981) (2)
Specific thromboxane synthetase inhibition and retinopathy in insulin-dependent diabetics. (1986) (2)
Diabetes : best practice & research compendium (2006) (2)
Genetic susceptibility to multiple sclerosis in the Shanghai Chinese is not linked to the myelin basic protein gene microsatellite (1995) (2)
HLA and C4 polymorphism in diabetic microangiopathy. (1987) (2)
Periodontal disease and general health: implications for cardiovascular disease and diabetes (2009) (2)
Selection and education of patients for inhaled insulin (2007) (2)
Improving management of diabetic kidney disease: will GLP-1 receptor agonists have a role? (2020) (2)
Poor glycaemic control and retinopathy in non‐insulin‐dependent diabetes mellitus (1997) (2)
Perceptions of diabetes control among people with type 2 diabetes treated with basal insulin in Sweden, Switzerland, and the United Kingdom (2016) (2)
Immunogenetics of Diabetes (1986) (2)
Value of glycaemic control in diabetes (2008) (2)
Hypoglycaemia in Type 2 Diabetes – Clinical Consequences and Impact on Treatment (2010) (2)
National repositories of family material: important research resource. (1994) (2)
HLA and C4 Types in Diabetic Microangiopathy (1985) (2)
Liraglutide: a new option in the management of type 2 diabetes (2008) (2)
Once-weekly GLP-1R agonists: moving the goal posts. (2018) (2)
Effectiveness of enhanced diabetes care to patients of South Asian ethnicity: the United Kingdom Asian Diabetes Study (UKADS) - a cluster randomised controlled trial (2008) (2)
Serum Fluorescence “Protein Browning” in Elderly Patients with Diabetes Mellitus (1993) (1)
Emerging therapies in type 2 diabetes (2001) (1)
Rimonabant (Acomplia): a novel adjunctive treatment for obesity (2007) (1)
Central obesity and cardiovascular risk factors in south Asians and white Europeans with type 2 diabetes. A report from the United Kingdom Asian Diabetes Study (UKADS) (2009) (1)
Does amylin have a pathophysiological endocrine role in diabetes mellitus in man? (1994) (1)
Drug Therapy for Dyslipoproteinaemia (1990) (1)
Guidelines for type 2 diabetes: keeping a finger on the pulse. (2017) (1)
Tumour necrosis factor-beta polymorphism is unlikely to determine susceptibility to Type 1 (insulin-dependent) diabetes mellitus (1991) (1)
Introduction: beyond glycemic control in type 2 diabetes (2006) (1)
Free Radical Reaction Products in Diabetes Mellitus: Relationship to Microangiopathy (1985) (1)
Transracial studies of IDDM suggest that DR3-related genetic susceptibility may be DQ-encoded (1990) (1)
Long-term Glycemic Control in Patients with Diabetes? (2006) (1)
Needle‐free insulin: from dreams to reality (2006) (1)
Genetic variants conferring susceptibility to Alzheimer’s disease in the general population; do they also predispose to dementia in Down’s syndrome (2014) (1)
Diabetes and Cardiovascular Disease (2004) (1)
The Bgl II RFLP associated with type 1 diabetes in DR3-positive subjects is not due to a DQA1 promoter region polymorphism. (1994) (1)
Review: Pharmacotherapy as part of a weight management programme: a UK perspective (2007) (1)
ICS Research Gold Medal Abstract Presentations (2007) (1)
Insulin secretory capacity in newly diagnosed non-insulin dependent diabetics. (1983) (1)
Diabetes and CVD in South Asians: A review (2008) (1)
Beta-and alpha-adrenergic blockade and metabolic responses to insulin induced hypoglycaemia in diabetics. (1987) (1)
Specific thromboxane synthetase inhibition and haemostasis in insulin-dependent diabetics. (1986) (1)
The nucleotide sequence of two new DP alleles, DPA1*02015 and DPB1*8401, identified in a Chinese subject. (2000) (1)
The JBS-2 guidelines on prevention of cardiovascular disease in clinical practice: an opportunity missed. (2006) (1)
Effect of Gliclazide on Thromboxane B2 and Parameters of Platelet Aggregation in Non-Insulin Dependent Diabetes Mellitus (1988) (1)
Adopting more aggressive strategies for the management of renal disease in type 2 diabetes (2003) (1)
Trans-racial gene mapping identifies two MHC genes as susceptibility loci for insulin-dependent diabetes mellitus (1990) (1)
Rede fi ning the role of thiazolidinediones in the management of type 2 diabetes (2009) (1)
The immunogenetics of insulin-dependent (Type I) diabetes (1989) (1)
Low Plasma C4 Concentrations: Association with Microangiopathy in Insulin Dependent Diabetics (1984) (1)
Defining uncontrolled diabetes from the patient Perspective: A four-country study in People with type-2 Diabetes On Basal Insulin (2015) (1)
Superoxide Radical Production by Glycated Proteins (1986) (1)
Genetic Factors Associated with Insulin-Dependent Diabetes (1997) (1)
GAPP2™: Global survey of type 2 diabetes insulin analogue users shows extensive impact of self-treated hypoglycaemia and dosing irregularities on diabetes management in primary care (2013) (1)
Transferrinuria in Diabetes Mellitus (1988) (1)
Exubera: first inhaled insulin for the management of diabetes (2007) (1)
Pre-conception counselling in Asian women with non insulin dependent diabetes and impaired glucose tolerance. (1988) (1)
Effect ofbromocriptine onmaturity onset diabetes (1980) (1)
Early insulin initiation in type 2 diabetes (2012) (1)
Dydrogesterone and norethisterone regulate expression of lipoprotein lipase and hormone‐sensitive lipase in human subcutaneous abdominal adipocytes (2007) (1)
Hyperosmolar non-ketotic diabetes mellitus associated with metolazone (1985) (1)
ANALYSIS OF INSULIN GENE REGION-ENCODED SUSCEPTIBILITY TO TYPE-1 DIABETES IN A UK DATA SET (1992) (1)
Obesity and Diabetes: Barnett/Obesity and Diabetes (2006) (1)
Inhaled human insulin: a clinical perspective (2006) (1)
Linagliptin for elderly patients with type 2 diabetes – Authors' reply (2014) (1)
CLINICAL PRACTICE QUESTION Triple oral anti‐diabetic therapy in Type 2 diabetes (2003) (1)
Insulin secretory capacity, beta-thromboglobulin and blood viscosity in long standing, non-insulin dependent diabetics with and without microangiopathy. (1983) (1)
HYPERPROLACTINAEMIA AND GRAVES' DISEASE (1978) (1)
A multicentre study of the B‐DTM (Becton Dickinson) Pen as a delivery system for human insulin (1994) (1)
We-P11:101 The prevalence of metabolic syndrome amongst patients presenting for elective surgery, and its association with post-operative complications (2006) (0)
Review Article Banting Memorial Lecture 2011 ^ Diabetes—science, serendipity and common sense (2011) (0)
Microalbuminuria and Capillary Basement Membrane Thickening in Diabetic Peripheral Neuropathy (1986) (0)
The Association of HLA-DR Types and DQβ Gene Fragments with Insulin Dependent Diabetes in Afro-Caribbeans (1988) (0)
Beta-Blockers and Metabolic Responses to Insulin Induced Hypoglycaemia in Diabetics (1986) (0)
Expression of adiponectin mRNA in human adipose tissue depots in non-diabetic and diabetic patients (2002) (0)
Free Radical Lipid and Protein Oxidation in Diabetic Microangiopathy (1986) (0)
GAPP2™: One in Four Type 2 Diabetes Patients in Canada using Insulin Analogues had Irregularities in their Basal Insulin Dosing in the Preceding 30 Days. (2012) (0)
Overview of Current Diabetes Management (2013) (0)
Erythrocyte Sodium Pump Activity in Diabetes Mellitus and its Relationship to Control and Microangiopathy (1985) (0)
Does Diabetic Microangiopathy Affect the Lung (1988) (0)
Calcitonin Gene Related Peptide (CGRP)II mRNA in human subcutaneous adipose tissue is altered by menopausal status (2005) (0)
Epidemiology and Pathogenesis of Type 2 Diabetes (2013) (0)
Increased prevalence of retinopathy in patients of South Asian ethnicity persists, even after adjustment for potentially confounding risk factors (2008) (0)
The Effects of Hyperglycaemia on the Red Blood Cell Glyoxalase System in Diabetic Patients and in Vitro (1988) (0)
Linkage of chromosome 6 and type 1 diabetes. (1996) (0)
Glitazones: the evidence from PROactive, DREAM and ADOPT (2007) (0)
Does the Val262Leu polymorphism in the mitochondial rhomboid protease PSARL predispose to type 2 diabetes in South Asians (2006) (0)
PMH20 Metabolic Consequences and Cost-Effectiveness of Asenapine in the Treatment of Bipolar Disorder (2012) (0)
Higher prevalence diabetic retinopathy in south Asians compared to Caucasians: a substudy from UKADS (United Kingdom Asian Diabetes Study) (2007) (0)
Interview: Importance of getting the diabetes message out there (2013) (0)
IDegLira: combining efficacy, durability, and convenience? (2019) (0)
Low serum C4 concentrations and diabetic complications (1986) (0)
GAPP2™: One Third of Canadian Type 2 Diabetes Patients using Basal Insulin Analogue Experienced Self-treated Hypoglycemia in the Preceding 30 Days and These Events Affect their Diabetes Management (2012) (0)
Albumin Excretion Rate and Plasma Renin Activity in Insulin Dependent Diabetes Mellitus (1988) (0)
Effect of Gliclazide on Free Radical Mediated Oxidation Products in Non-Insulin Dependent Diabetes Mellitus (1988) (0)
Editorial (2003) (0)
HLA-DR Associations with Insulin-Dependent Diabetes Mellitus in Black West Indians Resident in the UK (1988) (0)
GAD and IA2 autoantibody positivity is associated with a requirement for insulin treatment: results of the UK national paediatric Type 2 Diabetes cohort (2013) (0)
Fructosamine Estimation in Pregnant and Non-Pregnant Diabetics (1986) (0)
Asian patients with diabetes (1985) (0)
Sitagliptin Review of its Use in the Management of Type 2 (2010) (0)
Effect of Statil Therapy on Diene Conjugates and Reduced Glutathione in Diabetes Mellitus: An Investigation of the Redox Sparing Effect of Aldose Reductase Inhibition (1989) (0)
Physiology and pathophysiology of the Islets of Langerhans. Bernat Soria, Plenum Press, New York & London, 1998, 457, 210 × 150mm, Hardback, 0‐036457024, £75.00 (1999) (0)
Influence of Diabetic Control on Platelet Aggregation (1985) (0)
Erratum: The role of genetic polymorphisms within the renin-angiotensin system in susceptibility to diabetic nephropathy in IDDM subjects (Journal of the British Diabetic Association (1996) 13 (92)) (1996) (0)
ACE, ARB Equally Effective at Slowing Renal Damage DETAIL is the first long-term, head-to-head trial of the two drug classes in patients with type 2 diabetes. (2004) (0)
Lipid Peroxidation Products in Patients with Insulin Dependent Diabetes Mellitus (1988) (0)
An Alternative Explanation for the Changesin Erythrocyte Fatty AcidsObserved in Diabetes Mellitus (1987) (0)
Abnormalities of Platelet Aggregation in Diabetic Patients with Symptomatic Peripheral Neuropathy (1985) (0)
Tight glycemic control – an essential aim Insulin glargine in the treatment of type 1 and type 2 diabetes (2006) (0)
Ferroxidase Activity and the Fructosamine Assay in Diabetic Pregnancy (1988) (0)
Type 2 diabetes in childhood: building a platform for interventions to prevent the progression to cardiovascular disease (2010) (0)
Potential Problems of Serum Fructosamine Analysis as a Measure of Control in Diabetes Mellitus (1985) (0)
Cardiovascular risk targets in type 2 diabetes should be lower for patients of south Asian ethnicity : the United Kingdom Asian Diabetes Study (UKADS) (2008) (0)
Abnormalities of Ascorbic Acid (Vitamin C) Metabolism in Elderly Patients with Diabetes Mellitus (1990) (0)
HLA-DQA1,-DQB1 and-DRB1 alleles in a population from Jamaica (2004) (0)
Molecular genetics of Type 1 diabetes (1992) (0)
Clinical Management of Hypertension in Diabetes: Pocketbook (2001) (0)
The aetiology and genetics of type 1 diabetes (2006) (0)
West Indian patients attending a diabetic clinic in the U.K. (1987) (0)
SMBG: not an area for cost saving (2009) (0)
Lipid treatment strategies for metabolic syndrome in established cardiovascular disease: a consensus guideline (2006) (0)
Rare C4 Phenotypes and Their Relationship to Insulin Dependent Diabetes and its Microangiopathic Complications (1985) (0)
Conditional ETDT analysis of the human leukocyte antigen region in type 1 diabetes. (2000) (0)
Poor glycaemic control and retinopathy in non-insulin-dependent diabetes mellitus. (1997) (0)
Meta-Analysis of Individual Participant Data in Randomized Trials of Self-Monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes Patients (2011) (0)
Tight glycaemic control‐caution in high risk groups (2011) (0)
HLA‐D Region RFLPs and Type 1 Diabetes (1988) (0)
Reduced telomere length, a marker of biological senescence, is inversely correlated with triglycerides and cholesterol in South Asian male type 2 diabetic patients (2007) (0)
IS IT TIME TO TRANSFORM OUR TREATMENT OF TYPE 2 DIABETES? Summary of Presentations from the Bristol Myers Squibb/ AstraZeneca Alliance Symposium, European Association for the Study of Diabetes (EASD) 49 th Annual Congress, (2013) (0)
University of Birmingham Common variants of the TCF7L2 gene are associated with increased risk of type 2 diabetes mellitus in a UK-resident South Asian population (2008) (0)
Once-Weekly GLP-1 Receptor Agonists: Moving The Goal Posts (2018) (0)
SGLT2 inhibitors in older adults: overcoming the age barrier. (2023) (0)
Ferroxidase Activity of Caeruloplasmin in Diabetes (1986) (0)
Acipimox and hypertriglyceridaemia. (1990) (0)
Metaanalysis of "individual date of 2552 patients" issed in 6 randomized trials on the efficiency of ASG in non-insulin treated type 2 diabetic patients (2012) (0)
Individual insulin use and the risk of breast cancer: An international clinical epidemiology study. (2013) (0)
Replication of European GWAS-derived type 2 diabetes susceptibility SNPs in Pakistani populations (2010) (0)
Angiotensin Receptor Blockers and Type 2 Diabetic Nephropathy (2006) (0)
HLA-DR Antigens and DQ Beta Chain Gene Probing in Insulin Dependent Diabetics of Asian Origin (1986) (0)
HLA-Dr Typing by Restriction Fragment Length Polymorphism (RFLP) Analysis (1987) (0)
We-P11:67 Undiagnose diabetes and impaired fasting glycaemia amongst patients presenting for surgery, and their impact on post-operative outcomes (2006) (0)
PMH37 UNITED KINGDOM COST-CONSEQUENCE ANALYSIS OF ARIPIPRAZOLE IN SCHIZOPHRENIA: DIABETES AND CORONARY HEART DISEASE RISK PROJECTIONS (STAR STUDY) (2008) (0)
Expression of adiponectin protein in human fat: the effect of type 2 diabetes and obesity (2003) (0)
Serum Angiotensin Converting Enzyme Activity: Relationship to Retinopathy in Insulin Dependent Diabetes (1985) (0)
ICS Research Gold Medal Abstract Presentations The impact of abnormal glucose homeostasis on the outcome of intensive care patients ICS Research Gold Medal Abstract Presentations The impact of abnormal glucose homeostasis on the outcome of intensive care patients (2007) (0)
Pathogenesis of type 1 (insulin‐dependent) diabetes—implications for the 1990s (1990) (0)
NICE gives rimonabant the green light (2008) (0)
POSSIBLE ROLE OF INSULIN DEFICIENCY AND GROWTH HORMONE IN SEVERE RETINOPATHY (1985) (0)
Telmisartan and enalapril in type 2 diabetes Diabetics Exposed to Telmisartan and Enalapril (DETAIL) study (2005) (0)
Organization of Diabetes Care (2013) (0)
Bariatric Surgery for the Treatment of Type 2 Diabetes (2013) (0)
Saxagliptin a New Second Line Therapy After Metformin for the Treatment of Type 2 Diabetes (2010) (0)
[The major challenge of daily glycemic control in patients with type 2 diabetes mellitus. Introduction]. (2010) (0)
The Effect of a Specific Thromboxane Synthetase Inhibitor on Coagulation Parameters in Insulin Dependant Diabetics (1985) (0)
Latent autoimmune diabetes in adults (LADA) in the UK South Asian population (2007) (0)
Will pulmonary insulin delivery help improve type 1 and type 2 diabetes care (2004) (0)
Genetics of type 1 diabetes mellitus. (1992) (0)
Incidence, worry and discussion of self-treated hypoglycaemia amongst UK patients with Type 2 diabetes and prescribers: results from the Global Attitudes of Patient and Physicians (GAPP2 (TM)) survey (2013) (0)
Sodium‐Glucose Cotransporter‐2 Inhibitors (2013) (0)
Insulin icodec: evolution or revolution in diabetes therapy? (2023) (0)
Meeting on diabetic complications and early treatment using ACE inhibitors. (1996) (0)
Chapter 9 Management of type 2 diabetes and insulin (2011) (0)
DQβ DNA polymorphism analysis of IDDM in negroes suggests that a component of genetic susceptibility is DQ-encoded (1990) (0)
Inhaled Human Insulin (Exubera ® ): An Opportunity for Improving Long- Term Glycaemic Control in Patients with Diabetes? (2006) (0)
Th-P15:182 Is serum HDL a prognostic indicator in critically ill patients with stress hyperglycaemia? (2006) (0)
University of Birmingham Peripheral and Autonomic Neuropathy in South Asians and White Caucasians with Type 2 Diabetes Mellitus (2017) (0)
Lack of association of the insulin gene region with Grave's disease in the UK (2002) (0)
Controlling blood pressure in type-2 diabetes (2008) (0)
Evidence for a Role of Reactive Oxygen Species in the ‘Browning’ of Albumin (1988) (0)
Short Communication Nitric oxide synthase gene polymorphisms and diabetic nephropathy (2003) (0)
New Perspectives on the Management of Type 2 Diabetes: Report of symposia at the Royal College of Physicians, London, 16 April 2008 and Hilton Hotel, Coventry, 14 May 2008 (2008) (0)
Pipeline Diabetes Therapies (2013) (0)
In defence of NICE draft type 2 diabetes guidelines--Author's reply. (2015) (0)
Rimonabant in the management of cardiovascular risk (2008) (0)
Diminished Antioxidant Reserve in Elderly Diabetics with Microangiopathy (1989) (0)
Rosiglitazone inhibits insulin-mediated rise in angiotensinogen expression and angiotensin II secretion in human subcutaneous adipocytes (2002) (0)
Haemostatic Variables in Patients with Insulin Dependent Diabetes Mellitus (1988) (0)
Iscandidiasis thetruecauseofvulvovaginal irritation inwomen withdiabetes mellitus (1990) (0)
HLA-DR Types and Autoimmunity in Insulin Dependent Diabetics of Asian Origin in the West Midlands (1986) (0)
Glucose tolerance testing for all? (2007) (0)
Treating severe pneumonia in children: we can do better (2008) (0)
Neighborhood Environment Walkability Scale for Youth for the International Physical Activity and the Environment Network Adolescent Study (2021) (0)
LETTERS (1989) (0)
Dyslipidaemia in diabetes--a GP guide. (2002) (0)
Platelet Aggregation and Coagulation Factors in Insulin Dependant Diabetes (IDD) (1985) (0)
Core Evidence Lixisenatide : evidence for its potential use in the treatment of type 2 diabetes (2011) (0)
Introduction: the role of the thiazolidinediones in the cardiovascular risk management of type 2 diabetes (2005) (0)
Clinical management of hypertension in diabetes (2001) (0)
The female preponderance to autoimmune thyroid disease is reduced in multiplex type 1 diabetes families (2002) (0)
CTLA-4 region predisposes to IDDM and Graves' disease (1996) (0)
Minimising polypharmacy in hypertension (2009) (0)
Short sleep duration is independently associated with obesity in with Type 2 diabetes (2010) (0)
RATIONALE AND DESIGN OF DIABETICS EXPOSED TO TELMISARTAN AND ENALAPRIL (DETAIL STUDY): P2.31 (2000) (0)
JUMP: Maternal family history of diabetes and non-white ethnicity adversely affects beta cell response in young people with Type 2 Diabetes (2017) (0)
Fixed, flexible and self‐mixing of insulin: Relationship to glycaemic control (1996) (0)
Knowledge about the menopause and hormone therapy among women without diabetes attending general medical clinics and among women attending diabetes clinics in a West Midlands hospital (2004) (0)
Ethnicity and the risk of hypertension (2007) (0)
Microalbuminuria in Diabetic Patients: An Association with Chronic Peripheral Neuropathy (1988) (0)
Liraglutide, a new diabetes treatment approved by NICE (2010) (0)
' s response to reviews Title : Common variants of the TCF 7 L 2 gene are associated with increased risk of type 2 diabetes mellitus in a UK-resident South Asian population (2007) (0)
Review for "Prototype of an evidence‐based tool to aid individualized treatment for type 2 diabetes" (2020) (0)
' s response to reviews Title : Common variants of the TCF 7 L 2 gene are associated with increased risk of type 2 diabetes mellitus in a UK-resident South Asian population (2007) (0)
Specific Thromboxane Synthetase Inhibition and Microalbumin Excretion Rate in Insulin Dependent Diabetics (1984) (0)
The expression of resistin mRNA in human adipose tissue (2002) (0)
Lack of association of the interleukin 4 receptor gene with Graves' disease in the UK (2003) (0)
Type 2 Diabetes: Prediction and Prevention. Graham Hitman (editor). Chichester: John Wiley & Sons, Ltd, 1999. No. of pages: 402. Price: £80.00. ISBN: 0471985953 (1999) (0)
Diabetes annual 2002 (2002) (0)
Not again! Another clinical trial end‐point narrowly missed (2008) (0)
Specific Thromboxane Synthetase Inhibition and Diabetic Retinopathy in Insulin Dependent Diabetics (1985) (0)
White UK children are older, more obese and more insulin resistant than non-White UK children at diagnosis of type 2 diabetes: baseline results of the UK national type 2 diabetes cohort (2012) (0)
Metabolic studies in chlorpropamide-alcohol flush positive and negative Type 2 (non-insulin dependent) diabetic patients with and without retinopathy (1983) (0)
How to support a patient with Type 2 diabetes who is determined to undertake a period of religious fasting (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Anthony. H. Barnett?

Anthony. H. Barnett is affiliated with the following schools:

Anthony. H. Barnett's Academic­Influence.com Rankings

Why Is Anthony. H. Barnett Influential?

Anthony. H. Barnett's Published Works

Published Works

What Schools Are Affiliated With Anthony. H. Barnett?

Anthony. H. Barnett's AcademicInfluence.com Rankings